The CBD list in numbers

the CBD list in numbers

Cannabinoid Insight has monitored the various numbers and statements made since the publication of the CBD list by the Food Standards Agency (FSA) in March. Here is how things stand in April 2022, in the weeks after the list went live. Since 1 January 2021, the FSA has received over 900 novel food applications for CBD […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]

New report on THC in the UK makes recommendations for consumer CBD products

A recent report on THC levels in the UK has made a number of recommendations to the Home Office. The cannabinoids, THC, THC-V and CBN are controlled substances under the Misuse of Drugs Act. The Home Office has long maintained a 1mg threshold for controlled cannabinoids in any CBD product designed for consumer use, regardless […]